Carson Wealth (CWM LLC)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
Carson Wealth (CWM LLC)'s TXG Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its 10x Genomics (TXG) stake by 0.13% in Q1 2026, selling an estimated $3.32K and leaving 124,804 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #1077.
Carson Wealth (CWM LLC) first reported a position in TXG in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.86M in Q1 2023. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- Carson Wealth (CWM LLC) held 124,804 shares of 10x Genomics worth $2.65M as of Q1 2026.
- Carson Wealth (CWM LLC) sold 166 10x Genomics shares in Q1 2026, an estimated $3.32K.
- 10x Genomics made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1077 holding.
- Carson Wealth (CWM LLC) first reported a position in 10x Genomics in Q4 2021 and has held it in 18 quarters since.
- Carson Wealth (CWM LLC)'s 10x Genomics position peaked at $3.86M in Q1 2023.
- 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.